Movement Alert|Planet Labs Pbc Rises 7.3% in Pre-Market Trading, Q2 Revenue Significantly Beats Expectations with 58% YoY Growth

Market Focus
Sep 04

On September 4, Planet Labs Pbc rose 7.3% in pre-market trading, trading at approximately $19.78/share with turnover of $685,400, extending the post-earnings rebound from the prior session's after-hours trading.

The rally was driven by the company's fiscal Q2 results released after the previous close. Planet Labs reported revenue of $116.1 million for the quarter ended July 31, up 58.2% year-over-year and significantly exceeding the analyst consensus estimate of $104.5 million. Adjusted EPS came in at a loss of $0.03, slightly missing the expected loss of $0.02. The stock had declined over 5% during the prior regular session amid pre-earnings selling pressure, but quickly reversed following the strong revenue beat.

However, the company's Q3 revenue guidance of $101 million to $105 million fell notably short of the $114 million analyst estimate, which may cap further upside. Full-year fiscal 2027 revenue guidance of $430 million to $441 million was largely in line with the $435.8 million consensus. Additionally, Berenberg Bank recently initiated coverage with a Buy rating and a $25 price target, while the company announced a seven-figure annual contract with a European defense and intelligence client.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10